MIT brain researchers have developed a “cocktail” of dietary supplements, now in human clinical trials, that holds promise for the treatment of Alzheimer’s disease.
MIT brain researchers have developed a “cocktail” of dietary supplements, now in human clinical trials, that holds promise for the treatment of Alzheimer’s disease.
